ARVO 2021: Varenicline Nasal Spray Provides Relief for Dry Eye Disease in Phase III Study
The nicotinic acetylcholine receptor agonist delivered in the nasal spray stimulates the production of a tear film
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.